Cholesterol Testing Products and Services Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Test, By Age Group, By Application, By Service Providers, By Region & Competition, 2021-2031F

Description

The Global Cholesterol Testing Products & Services Market is projected to experience significant expansion, growing from a valuation of USD 20.38 Billion in 2025 to USD 33.95 Billion by 2031, registering a CAGR of 8.88%. This market encompasses a broad array of diagnostic instruments, reagents, and test kits, alongside professional laboratory services designed for the detection and management of hyperlipidemia. The primary drivers of this growth include the escalating incidence of cardiovascular conditions and an aging global population that requires consistent monitoring of lipid profiles. Furthermore, the growing focus on preventive medicine is fostering a sustained demand for early detection capabilities across a variety of healthcare environments.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 20.38 Billion
Market Size 2031	USD 33.95 Billion
CAGR 2026-2031	8.88%
Fastest Growing Segment	Testing Kits
Largest Market	North America

However, the market's upward trajectory is moderated by challenges such as variable reimbursement frameworks, which can limit patient access to necessary testing procedures. For instance, data from the British Heart Foundation indicated that in 2025, approximately 7.6 million individuals in the United Kingdom were living with heart and circulatory diseases. While this statistic underscores the immense burden of disease necessitating diagnostic intervention, economic constraints within healthcare funding systems continue to pose a formidable barrier to the widespread adoption of these products.

Market Driver

The escalating global prevalence of cardiovascular diseases acts as the primary catalyst for the Global Cholesterol Testing Products & Services Market, creating an urgent need for frequent and precise lipid monitoring to reduce mortality risks. As the incidence of heart-related conditions rises worldwide, healthcare systems are prioritizing diagnostic interventions to identify at-risk populations early, a burden that is particularly evident in developed nations. According to the Centers for Disease Control and Prevention's 'Heart Disease Facts' report from October 2024, 919,032 people in the United States died from cardiovascular disease in 2023, underscoring the critical need for robust testing infrastructure to manage patient health effectively. This demand is reflected in commercial performance; Abbott reported in its 'Third-Quarter 2024 Financial Results' in October 2024 that global Core Laboratory Diagnostics sales increased by 4.5% on an organic basis, driven by the sustained adoption of routine diagnostic testing systems.

Supportive government initiatives promoting routine health screenings are further driving market expansion by actively removing barriers to preventive care and improving diagnostic accessibility. Public health bodies are increasingly implementing large-scale screening programs to manage long-term cardiovascular risks, thereby securing a steady volume of testing procedures. For example, the National Audit Office's November 2024 report, 'Progress in preventing cardiovascular disease,' noted that the NHS in England has set a national ambition to prevent 150,000 heart attacks and strokes by 2029 through improved detection and management of high cholesterol and blood pressure. Such state-sponsored mandates not only validate the clinical necessity of regular lipid profiling but also incentivize the adoption of advanced testing services across community health settings, fostering a conducive environment for market growth.

Market Challenge

Inconsistent reimbursement structures and economic constraints within healthcare funding constitute significant barriers to the expansion of the Global Cholesterol Testing Products & Services Market. When insurance coverage is variable or limited, patients are often compelled to pay out-of-pocket for routine lipid profiling, which discourages widespread participation in preventive screening programs. This lack of financial accessibility directly reduces the volume of diagnostic tests administered, particularly among asymptomatic populations who might otherwise seek early detection, thereby stalling revenue generation for reagents and laboratory services.

The immense financial pressure on healthcare infrastructures further exacerbates this issue, causing payers to scrutinize and restrict spending on diagnostic procedures. According to the European Society of Cardiology, in 2024, cardiovascular disease was estimated to cost the EU economy €282 billion annually. This staggering economic burden forces health administrations to prioritize funds for acute interventions rather than preventive diagnostics. Consequently, manufacturers encounter a restrictive market environment where budgetary limitations and reimbursement caps hinder the procurement of testing products, directly impeding the industry's ability to sustain growth.

Market Trends

The rise of Direct-to-Consumer (DTC) laboratory testing services is fundamentally altering patient engagement models by enabling individuals to order screenings without physician consultation. This shift empowers consumers to proactively manage their cardiovascular health, increasing the volume of lipid panels processed outside traditional pathways, while diagnostic providers scale these platforms to capture health-conscious users seeking convenience. For example, according to Quest Diagnostics' 'Fourth Quarter and Full Year 2024 Financial Results' released in January 2025, the company expanded its consumer-initiated platform to include approximately 135 tests, broadening access to screenings such as high-risk Lipoprotein(a) cholesterol testing, a strategy that diversifies laboratory revenue while stimulating demand for direct-access reagent kits.

Simultaneously, the adoption of artificial intelligence for predictive lipid profiling is revolutionizing risk stratification by identifying high-risk patients who might otherwise remain undiagnosed. Algorithms are now capable of analyzing electronic medical records to flag individuals with probable genetic lipid disorders before cardiovascular events occur, shifting the market focus from reactive testing to proactive, data-driven surveillance. Highlighting this advancement, an August 2025 article in Cardiovascular Business titled 'Health systems use AI to target patients who may have elevated Lp(a) levels' noted that the Family Heart Foundation partnered with seven large healthcare systems to utilize artificial intelligence for identifying patients with undiagnosed high lipoprotein(a) levels, thereby driving the utilization of confirmatory diagnostic assays.

Key Market Players

Roche Diagnostics
Abbott
Siemens Healthineers
Beckman Coulter
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Bio-Rad
Danaher
Sekisui Diagnostics
NowDiagnostics

Report Scope

In this report, the Global Cholesterol Testing Products & Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cholesterol Testing Products & Services Market, By Product

Testing Kits
Testing Strips
Others

Cholesterol Testing Products & Services Market, By Test

Total Cholesterol Tests
High Density Lipoprotein (HDL) Cholesterol Tests
Low Density Lipoprotein (LDL) Cholesterol Tests
Triglyceride Tests
Others

Cholesterol Testing Products & Services Market, By Age Group

Geriatric
Adult
Pediatric

Cholesterol Testing Products & Services Market, By Application

Cardiovascular Diseases
Diabetes
Obesity
Hyperlipidemia
Others

Cholesterol Testing Products & Services Market, By Service Providers

Hospitals and Clinics
Diagnostic Laboratories
Ambulatory Care Centers
Others

Cholesterol Testing Products & Services Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cholesterol Testing Products & Services Market.

Available Customizations:

Global Cholesterol Testing Products & Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cholesterol Testing Products & Services Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Testing Kits, Testing Strips, Others)
- 5.2.2. By Test (Total Cholesterol Tests, High Density Lipoprotein (HDL) Cholesterol Tests, Low Density Lipoprotein (LDL) Cholesterol Tests, Triglyceride Tests, Others)
- 5.2.3. By Age Group (Geriatric, Adult, Pediatric)
- 5.2.4. By Application (Cardiovascular Diseases, Diabetes, Obesity, Hyperlipidemia, Others)
- 5.2.5. By Service Providers (Hospitals and Clinics, Diagnostic Laboratories, Ambulatory Care Centers, Others)
- 5.2.6. By Region
- 5.2.7. By Company (2025)
5.3. Market Map

6. North America Cholesterol Testing Products & Services Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Test
- 6.2.3. By Age Group
- 6.2.4. By Application
- 6.2.5. By Service Providers
- 6.2.6. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Cholesterol Testing Products & Services Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Test
    - 6.3.1.2.3. By Age Group
    - 6.3.1.2.4. By Application
    - 6.3.1.2.5. By Service Providers
- 6.3.2. Canada Cholesterol Testing Products & Services Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Test
    - 6.3.2.2.3. By Age Group
    - 6.3.2.2.4. By Application
    - 6.3.2.2.5. By Service Providers
- 6.3.3. Mexico Cholesterol Testing Products & Services Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Test
    - 6.3.3.2.3. By Age Group
    - 6.3.3.2.4. By Application
    - 6.3.3.2.5. By Service Providers

7. Europe Cholesterol Testing Products & Services Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Test
- 7.2.3. By Age Group
- 7.2.4. By Application
- 7.2.5. By Service Providers
- 7.2.6. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Cholesterol Testing Products & Services Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Test
    - 7.3.1.2.3. By Age Group
    - 7.3.1.2.4. By Application
    - 7.3.1.2.5. By Service Providers
- 7.3.2. France Cholesterol Testing Products & Services Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Test
    - 7.3.2.2.3. By Age Group
    - 7.3.2.2.4. By Application
    - 7.3.2.2.5. By Service Providers
- 7.3.3. United Kingdom Cholesterol Testing Products & Services Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Test
    - 7.3.3.2.3. By Age Group
    - 7.3.3.2.4. By Application
    - 7.3.3.2.5. By Service Providers
- 7.3.4. Italy Cholesterol Testing Products & Services Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Test
    - 7.3.4.2.3. By Age Group
    - 7.3.4.2.4. By Application
    - 7.3.4.2.5. By Service Providers
- 7.3.5. Spain Cholesterol Testing Products & Services Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Test
    - 7.3.5.2.3. By Age Group
    - 7.3.5.2.4. By Application
    - 7.3.5.2.5. By Service Providers

8. Asia Pacific Cholesterol Testing Products & Services Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Test
- 8.2.3. By Age Group
- 8.2.4. By Application
- 8.2.5. By Service Providers
- 8.2.6. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Cholesterol Testing Products & Services Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Test
    - 8.3.1.2.3. By Age Group
    - 8.3.1.2.4. By Application
    - 8.3.1.2.5. By Service Providers
- 8.3.2. India Cholesterol Testing Products & Services Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Test
    - 8.3.2.2.3. By Age Group
    - 8.3.2.2.4. By Application
    - 8.3.2.2.5. By Service Providers
- 8.3.3. Japan Cholesterol Testing Products & Services Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Test
    - 8.3.3.2.3. By Age Group
    - 8.3.3.2.4. By Application
    - 8.3.3.2.5. By Service Providers
- 8.3.4. South Korea Cholesterol Testing Products & Services Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Test
    - 8.3.4.2.3. By Age Group
    - 8.3.4.2.4. By Application
    - 8.3.4.2.5. By Service Providers
- 8.3.5. Australia Cholesterol Testing Products & Services Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Test
    - 8.3.5.2.3. By Age Group
    - 8.3.5.2.4. By Application
    - 8.3.5.2.5. By Service Providers

9. Middle East & Africa Cholesterol Testing Products & Services Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Test
- 9.2.3. By Age Group
- 9.2.4. By Application
- 9.2.5. By Service Providers
- 9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Cholesterol Testing Products & Services Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Test
    - 9.3.1.2.3. By Age Group
    - 9.3.1.2.4. By Application
    - 9.3.1.2.5. By Service Providers
- 9.3.2. UAE Cholesterol Testing Products & Services Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Test
    - 9.3.2.2.3. By Age Group
    - 9.3.2.2.4. By Application
    - 9.3.2.2.5. By Service Providers
- 9.3.3. South Africa Cholesterol Testing Products & Services Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Test
    - 9.3.3.2.3. By Age Group
    - 9.3.3.2.4. By Application
    - 9.3.3.2.5. By Service Providers

10. South America Cholesterol Testing Products & Services Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Test
- 10.2.3. By Age Group
- 10.2.4. By Application
- 10.2.5. By Service Providers
- 10.2.6. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Cholesterol Testing Products & Services Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Test
    - 10.3.1.2.3. By Age Group
    - 10.3.1.2.4. By Application
    - 10.3.1.2.5. By Service Providers
- 10.3.2. Colombia Cholesterol Testing Products & Services Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Test
    - 10.3.2.2.3. By Age Group
    - 10.3.2.2.4. By Application
    - 10.3.2.2.5. By Service Providers
- 10.3.3. Argentina Cholesterol Testing Products & Services Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Test
    - 10.3.3.2.3. By Age Group
    - 10.3.3.2.4. By Application
    - 10.3.3.2.5. By Service Providers

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Cholesterol Testing Products & Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Roche Diagnostics
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Abbott
15.3. Siemens Healthineers
15.4. Beckman Coulter
15.5. Ortho Clinical Diagnostics
15.6. Thermo Fisher Scientific
15.7. Bio-Rad
15.8. Danaher
15.9. Sekisui Diagnostics
15.10. NowDiagnostics